Cargando…
The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis
OBJECTIVE: Although the prognostic value of programmed cell death-ligand 1 (PD-L1) expression in non-Hodgkin lymphoma (NHL) has been evaluated in many studies, the results remain controversial. To investigate the prognostic role of PD-L1 expression and the association between PD-L1 expression and cl...
Autores principales: | Zhao, Shu, Zhang, Minghui, Zhang, Yu, Meng, Hongxue, Wang, Yan, Liu, Yupeng, Jing, Jing, Huang, Lan, Sun, Mengqi, Zhang, Yue, Zhang, Qingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121049/ https://www.ncbi.nlm.nih.gov/pubmed/30197796 http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0047 |
Ejemplares similares
-
TLR4 expression correlated with PD-L1 expression indicates a poor prognosis in patients with peripheral T-cell lymphomas
por: Zhao, Shu, et al.
Publicado: (2019) -
Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis
por: Zhu, Zhenhua, et al.
Publicado: (2017) -
Programmed Death 1 (PD-1) Expression in Relapsing and Remitting Hodgkin Lymphoma as Prognostic Factor
por: Bouzari, Behnaz, et al.
Publicado: (2023) -
High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma
por: Guo, Xiaofang, et al.
Publicado: (2018) -
VEGF Overexpression Is a Valuable Prognostic Factor for Non-Hodgkin's Lymphoma Evidence from a Systemic Meta-Analysis
por: Yang, Jing, et al.
Publicado: (2015)